The Effectiveness of Mindfulness-Based Cognitive Therapy on Dysfunctional Career Thoughts in Nursing Students

by S Poordad, P Varaee
Published 2019-07-01

Review: Rapid virological response to peginterferon alfa and ribavirin treatment of chronic hepatitis C predicts sustained virological response and relapse in genotype 1 patients

by Fred Poordad, Carmen Landaverde
Published 2009-03-01

Evaluation of Performance of the Vestibular Proprioception and Vision Systems on Postural Control of Old Men

by Poordad Kiyani, Nader Farahpoor
Published 2015-10-01

Death Anxiety and Its Relationship With Social Support and Gratitude in Older Adults

by Saba Poordad, Khodamorad Momeni, Jahangir karami
Published 2019-05-01

Hepatic Encephalopathy: A Paradigm Shift

by Dieter Haussinger, Peter Jepsen, Rajiv Jalan, Fred Poordad
Published 2013-12-01

Evaluation of drought stress tolerance in promising lines of chickpea (Cicer arietinum L.) using drought resistance indices

by Akbar Shabani, Alireza Zebarjadi, Ali Mostafaei, Mohsen Saeidi, S. Saeed Poordad
Published 2018-06-01

Avatrombopag, an Alternate Treatment Option to Reduce Platelet Transfusions in Patients with Thrombocytopenia and Chronic Liver Disease-Integrated Analyses of 2 Phase 3 Studies

by Fred Poordad, Norah A. Terrault, Naim Alkhouri, Wei Tian, Lee F. Allen, Mordechai Rabinovitz
Published 2020-01-01

Percutaneous Liver Biopsy after Living Donor Liver Transplantation Resulting in Fulminant Hepatic Failure: The First Reported Case of Hepatic Compartment Syndrome

by Nicholas N. Nissen, Stephen A. Geller, Andrew Klein, Steve Colquhoun, David Yamini, Tram T. Tran, Benjamin Weinberg, Julie Winn, Fred Poordad
Published 2010-01-01

Simeprevir, daclatasvir, and sofosbuvir for hepatitis C virus‐infected patients: Long‐term follow‐up results from the open‐label, Phase II IMPACT study

by Eric Lawitz, Fred Poordad, Julio A. Gutierrez, Maria Beumont, Greet Beets, Ann Vandevoorde, Pieter Van Remoortere, Donghan Luo, Leen Vijgen, Veerle Van Eygen, Mohamed Gamil
Published 2020-06-01

The impact of an educational program on HCV patient outcomes using boceprevir in community practices (OPTIMAL trial)

by Fred Poordad, Vinod Rustgi, Robert S. Brown, Vishal Patel, Marcelo Kugelmas, Fredric Regenstein, Luis Balart, Douglas LaBrecque, Kimberly Brown, Mark Avila, Michael Biederman, Glenn Freed, Richard Smith, Marc Bernstein, Hays Arnold, Joel Cahan, Scott Fink, William Katkov, Hatef Massoumi, Stephen Harrison
Published 2015-09-01

P49 MAGELLAN-1, PART 2: glecaprevir and pibrentasvir for 12 or 16 weeks in patients with chronic HCV genotype 1 or 4 and prior direct-acting antiviral treatment failure

by Fred Poordad, Stanislas Pol, Armen Asatryan, Maria Buti, David Shaw, Christophe Hézode, Franco Felizarta, Robert W. Reindollar, Stuart C. Gordon, Stephen Pianko, Michael W. Fried, David E. Bernstein, Joel Gallant, Chih-Wei Lin, Yang Lei, Teresa I. Ng, Tami Pilot-Matias, Jens Kort, Federico Mensa
Published 2017-08-01